Assignee
SHANGHAI SINOBAY BIOTECHNOLOGY CO LTD
CN·0 granted patents·6 pending applications·0 citations·filing 2019–2022
Top patents by PatentIndex Score
6 records- 0162US2024368279A1Antibody Specifically Binding to CD47, Recombinant Oncolytic Virus Thereof and Use ThereofSHANGHAI SINOBAY BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0258US2025319126A1Condition-controlled spliceable chimeric antigen receptor molecule and application thereofSHANGHAI SINOBAY BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0358US2025297002A1Bispecific t-cell engager, recombinant oncolytic virus thereof, and use thereofSHANGHAI SINOBAY BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0458US2024343767A1Hypoxia-Triggered Artificial Transcription Factor, a Hypoxia-Triggered Transcription Control System and Use ThereofSHANGHAI SINOBAY BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0556US2025019446A1Antibody Targeting Axl Protein and Antigen Binding Fragment Thereof, and Preparation Method Therefor and Application ThereofSHANGHAI SINOBAY BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0651US2022177839A1Composition, culture medium and method for inducing and/or amplifying tscm in vitroSHANGHAI SINOBAY BIOTECHNOLOGY CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI SINOBAY BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →